Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions

Infectious Diseases

Answer 2
  1. When amantadine or rimantadine is administered as chemoprophylaxis, vaccination is unnecessary. This statement is incorrect. Although the antiviral drugs reduce the possibility of clinical disease, they do not provide any lasting protection. As soon as the prophylaxis is discontinued, the patient is vulnerable to infection. Assuming that immediate protection is needed (ie, the patient was not vaccinated or is traveling to the Pacific area or the Southern Hemisphere), antivirals can be used to provide protection during the “window phase” of vaccination when antibodies are developing. The antivirals do not interfere with the immune response to the vaccine.

Click here to return to the questions


Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/04/08 • kkj